Navigation Links
Global Insulin Antidiabetics Market 2012-2016
Date:3/7/2013

NEW YORK, March 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Insulin Antidiabetics Market 2012-2016

http://www.reportlinker.com/p01118262/Global-Insulin-Antidiabetics-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

TechNavio's analysts forecast the Global Insulin Antidiabetics Market 2012-2016 to grow at a CAGR of 12.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Insulin Antidiabetics market has also been witnessing the trend of an increase in awareness and education. However, the increase in use of complementary and alternative medicine could pose a challenge to the growth of this market.

TechNavio's report, the Global Insulin Antidiabetics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Insulin Antidiabetics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Novo Nordisk A/S, Sanofi S.A, and Eli Lilly and Co.

Key questions answered in this report:

What will the market size be in 2016 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

01. Executive Summary 02. Introduction 03. Market Coverage Market Overview Key Offerings 04. Market Landscape Market Size and Forecast 04.1 Patent Expiry Dates for Major Antidiabetics 04.2 Five Forces Analysis 05. Geographical Segmentation 06. Rate of Incidence and Prevalence 07. Vendor Landscape 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 14.1 Novo Nordisk A/S Business Overview Key Information SWOT Analysis 14.2 Sanofi S.A. Business Overview Key Information SWOT Analysis 14.3 Eli Lilly and Co. Business Overview Key Information SWOT Analysis 15. Other Reports in this Series

List of Exhibits: Exhibit 1: Global Insulin Antidiabetics Market 2012-2016 (US$ billion)

Exhibit 2: Global Insulin Antidiabetics Market Segmentation

Exhibit 3: Global Insulin Antidiabetics Market Segmentation 2012

Exhibit 4: Global Insulin Antidiabetics Market by Geographical Segmentation 2012

Exhibit 5: Global Insulin Antidiabetics Market by Vendor Segmentation 2012

To order this report:Drug_and_Medication Industry: Global Insulin Antidiabetics Market 2012-2016

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
2. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
3. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
4. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
5. Global Gynecological Devices Market is Expected to Reach USD 5.3 Billion by 2018: Transparency Market Research
6. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
9. Henry Schein to Present at the 2013 Barclays Global Healthcare Conference
10. Sequenom Announces Participation At The Barclays Global Healthcare Conference
11. Evofem Announces Strategic Alliance with WomanCare Global
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest ... the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive ... rare and deadly chromosome abnormality. , After struggling since birth with several health ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
Breaking Medicine News(10 mins):